Healthcare & Life Sciences News and Articles

Google News – Oncology External News

Funding Gap Between Overall Survival Data and Investor Near-Term Expectations Is Stalling Oncology Drug Development, Says Oncolytics Biotech CEO Jared Kelly - BioPharm International

news.google.com · 15 Jul 2026

Google News – Oncology External News

AstraZeneca Licenses Global Rights to Dizal Lung Cancer Drug for Up-to-$1.5B - Genetic Engineering and Biotechnology News

news.google.com · 14 Jul 2026

Google News – Biotech Funding External News

Biotech infrastructure review: where investment is flowing - The Pharma Letter

news.google.com · 14 Jul 2026

Google News – Biotech Funding External News

Pennsylvania state budget to pump $125M into life sciences industry starved for capital - The Business Journals

news.google.com · 14 Jul 2026

Google News – Biotech Funding External News

Judge orders Apple Tree partner to forfeit oversight of venture fund - BioPharma Dive

news.google.com · 14 Jul 2026

Google News – FDA (biotech/pharma) External News

FDA plans to release more drug rejection letters as controversial policy resumes - Fierce Biotech

news.google.com · 14 Jul 2026

Google News – Biotech Funding External News

European biotech chases record VC funding - PitchBook

news.google.com · 14 Jul 2026

Google News – Biotech Funding External News

European biotech chases record VC funding - Yahoo Finance

news.google.com · 14 Jul 2026

Google News – FDA (biotech/pharma) External News

“Hub-and-spoke” drug manufacturing set to benefit from new FDA rule - Pharmaceutical Technology

news.google.com · 13 Jul 2026

Google News – FDA (biotech/pharma) External News

FDA's latest onshoring move homes in on streamlined facility registration, foreign plant scrutiny - fiercepharma.com

news.google.com · 13 Jul 2026

Google News – Biopharma External News

Biotech startup funding gap widens despite rebound in VC investment - BioPharma Dive

news.google.com · 13 Jul 2026

Google News – Oncology External News

Agenus scraps phase 3 colorectal study after 3 months to narrow focus to colon cancer - Fierce Biotech

news.google.com · 13 Jul 2026

Google News – Biotech Funding External News

Biotech startup funding gap widens despite rebound in VC investment - Yahoo Finance

news.google.com · 12 Jul 2026

Google News – FDA (biotech/pharma) External News

FDA rejects Hengrui, Elevar’s PD-1 liver cancer combo for a 3rd time - Fierce Pharma

news.google.com · 10 Jul 2026

Google News – FDA (biotech/pharma) External News

Sanofi snags FDA thumbs up for Sarclisa as 1st cancer drug delivered by on-body injector - Fierce Pharma

news.google.com · 10 Jul 2026

News & Articles

The Frontline Signal: Turning Daily Friction Into Better Healthcare Hiring

The Digital Health Interpreter: Making Technology Usable in Care

The Pitt is up for 25 Emmys - but the show's biggest fans are real-life doctors

From Roster to Resilience: Building a Workforce Risk Register

The Protocol-to-Workflow Specialist: A Career Emerging in Clinical Research

Jury should decide if university’s hiring process was tainted by diversity goals, court rules

Running costs of vaccine damage scheme more than double amount paid to victims

CMS expands TAVR Medicare coverage to asymptomatic patients

Stryker stock falls on slower peripheral vascular, hip sales

Veterans Affairs taps Amwell for telehealth revamp - Healthcare Dive

8 stories on the healthcare affordability crunch

Campaigners hold vigil as stroke unit closes

Epidural Kit Correction: Medical Action Industries Issues Correction for Epidural Kits Containing Spectra Medical Devices Lidocaine Ampules

UK needs new laws for AI in healthcare, says watchdog

Migraines and acne among five more conditions pharmacists can treat

Maternal Mental Health Policy

4 questions about the FDA’s approach to generative AI

Presidential dialogue on high-threat pathogens

5 takeaways from Oura’s IPO filing

Contractors will bear repair costs for lift defects at Queen Mary Hospital, Hong Kong development chief says

Funding Gap Between Overall Survival Data and Investor Near-Term Expectations Is Stalling Oncology Drug Development, Says Oncolytics Biotech CEO Jared Kelly - BioPharm International

AstraZeneca Licenses Global Rights to Dizal Lung Cancer Drug for Up-to-$1.5B - Genetic Engineering and Biotechnology News

Biotech infrastructure review: where investment is flowing - The Pharma Letter

Pennsylvania state budget to pump $125M into life sciences industry starved for capital - The Business Journals

Judge orders Apple Tree partner to forfeit oversight of venture fund - BioPharma Dive

FDA plans to release more drug rejection letters as controversial policy resumes - Fierce Biotech

European biotech chases record VC funding - PitchBook

European biotech chases record VC funding - Yahoo Finance

“Hub-and-spoke” drug manufacturing set to benefit from new FDA rule - Pharmaceutical Technology

FDA's latest onshoring move homes in on streamlined facility registration, foreign plant scrutiny - fiercepharma.com

Biotech startup funding gap widens despite rebound in VC investment - BioPharma Dive

Agenus scraps phase 3 colorectal study after 3 months to narrow focus to colon cancer - Fierce Biotech

Biotech startup funding gap widens despite rebound in VC investment - Yahoo Finance

FDA rejects Hengrui, Elevar’s PD-1 liver cancer combo for a 3rd time - Fierce Pharma

Sanofi snags FDA thumbs up for Sarclisa as 1st cancer drug delivered by on-body injector - Fierce Pharma